Forms of fedratinib dihydrochloride
Abstract:
The present disclosure relates to novel forms of fedratinib dihydrochloride (diHCl) and processes for the preparation of the various forms. The present disclosure also relates to pharmaceutical compositions comprising the novel forms of fedratinib dihydrochloride and methods for treating disease using the forms.
Public/Granted literature
Information query
Patent Agency Ranking
0/0